Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the United States Patent and Trademark ...

Anaerobic bacteria were among the first life forms on Earth and existed at a time when there was no oxygen in the atmosphere.

Surprisingly, the pigments show an effect against certain microorganisms. The celluxanthenes have mild antibiotic activity against Gram-positive bacteria – including clinically relevant, resistant ...

To quantify antibiotics in ICU patients’ blood, dried blood spot analysis was sued alongside UHPLC–MS/MS to monitor these substances in a more convenient matter.

A brain abscess is a rare but life-threatening infection. Learn how advances in imaging, surgery, and diagnostics are ...

Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens ...

Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

Iterum Therapeutics plc (Nasdaq: ITRM) ("Iterum" or the "Company"), a company committed to delivering next generation oral and IV antibiotics to ...

Five evidence-based strategies to prevent UTIs after menopause - A team of experts has shared the proven strategies to help ...

View original content: https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-inc-announces-exercise-of-warrants-for-2-67-million-gross-proceeds-302484551.html ...

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) remained free ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...